MedPath

A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

Phase 2
Conditions
Macular Degeneration
Registration Number
NCT00032396
Lead Sponsor
Control Delivery Systems
Brief Summary

A study evaluating Retisert in patients with age-related macular degeneration

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Control Delivery Systems, Inc.

🇺🇸

Watertown, Massachusetts, United States

Control Delivery Systems, Inc.
🇺🇸Watertown, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.